June 11, 2008 Orion Genomics Gains Exclusive Worldwide Rights to the IGF2 Gene for Colorectal Cancer Risk Testing Through Licensing Agreement with Johns Hopkins University.
December 20, 2007 Orion Genomics discovers and validates novel breast cancer biomarkers, including the most frequent DNA alterations detected in breast cancer to date; publishes results in PLoS ONE.
April 14, 2007 Orion Genomics announces the discovery and validation of novel biomarkers for ovarian and lung cancer at the annual meeting of the American Association for Cancer Research.
» More News
